(2011) 589(Pt 4):96373
However, despite their significant therapeutic potential in cancer treatment, it is essential to also focus on managing immune-related adverse events (irAEs)
Thus, it is recommended to investigate for this AE in SGLT2i-treated patients with symptoms of ketoacidosis, such as nausea, vomiting, abdominal pain, ketonuria, and/or ketonemia, regardless of the current glucose status [74]
However, these symptoms often subside over time as the body adjusts
Minimum two to four weeks often required before judging effectiveness for chronic conditions, with some injuries needing six or more weeks to show meaningful response
This includes GABA, serotonin, and other neurotransmitters